# Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

> Research article (Pediatric Blood & Cancer, 2021) · cited 66× · AI/ML

**Wikidata**: [openalex:W3153758771](https://www.wikidata.org/wiki/openalex:W3153758771)  
**Source**: https://4ort.xyz/entity/temozolomide-with-irinotecan-versus-temozolomide-irinotecan-plus-bevacizumab-for-recurrent-medulloblastoma-of-childhood-